Coagulation laboratory tests
International normalized ratio (INR)
Reviewer: Jeremy Parsons, M.D. (see Reviewers page)
Revised: 10 February 2013, last major update November 2012
Copyright: (c) 2002-2013, PathologyOutlines.com, Inc.
● Used to standardize prothrombin time (PT) results for patients taking warfarin (coumadin)
● Intended to make comparisons similar between different labs by compensating for variable thromboplastins used in PT test
● Often used as an arbitrary level of “bleeding likelihood” (J Clin Pathol 2003;56:48 (recommendations for reporting))
● Generally only helpful when a patient is on warfarin and one is evaluating if patient is currently in warfarin therapeutic ranges, or if a warfarin reversal is being considered for upcoming intervention
● Patient self management may be effective (J Clin Pathol 2002;55:845 (patient self testing))
● Therapeutic goal is usually a value of 2 to 3
● Defined as patient PT divided by mean normal PT, with the result raised to the power (exponent) of the ISI
● Results can be improved with a calibration curve (Arch Pathol Lab Med 2004;128:308)
● Results are affected by different thromboplastin reagents, not by storage at room temperature for up to 24 hours (Arch Pathol Lab Med 1998;122:972)
End of Coagulation > Coagulation laboratory tests > International normalized ratio (INR)
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).